Erlotinib in advanced non-small-cell lung cancer after gefitinib failure

被引：0
|
作者：
Zheng-Tao Zhou
Xin-Hua Xu
Qing Wei
Ming-qian Lu
Jie Wang
Cai-Hong Wen
机构：
[1] China Three Gorges University,Oncology Department, The First College of Clinical Medical Science
[2] China Three Gorges University,Pharmacy Department, The First College of Clinical Medical Science
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Erlotinib; Gefitinib; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1123 / 1127
页数：4
相关论文
共 50 条
  • [1] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [2] EFFECTIVENESS OF ERLOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER AFTER FAILURE OF GEFITINIB
    Saito, Haruhiro
    Murakami, Shuji
    Honda, Takeshi
    Kondo, Tetsuro
    Oshita, Fumihiro
    Noda, Kazumasa
    Yamada, Kouzo
    ANNALS OF ONCOLOGY, 2010, 21 : 26 - 26
  • [3] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Grossi, Francesco
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Defferrari, Carlotta
    Brianti, Annalisa
    Barletta, Giulia
    Genova, Carlo
    Murolo, Carmelina
    Cosso, Maurizio
    Fontanini, Gabriella
    Boldrini, Laura
    Truini, Mauro
    Pronzato, Paolo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1407 - 1412
  • [4] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Francesco Grossi
    Erika Rijavec
    Maria Giovanna Dal Bello
    Carlotta Defferrari
    Annalisa Brianti
    Giulia Barletta
    Carlo Genova
    Carmelina Murolo
    Maurizio Cosso
    Gabriella Fontanini
    Laura Boldrini
    Mauro Truini
    Paolo Pronzato
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1407 - 1412
  • [5] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    Cho, Byoung Chul
    Im, Chong-Kun
    Park, Moo-Suk
    Kim, Se Kyu
    Chang, Joon
    Park, Jong Pil
    Choi, Hye Jin
    Kim, Yu Jin
    Shin, Sang-Joon
    Sohn, Joo Hyuk
    Kim, Hoguen
    Kim, Joo Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2528 - 2533
  • [6] Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
    Vasile, E.
    Tibaldi, C.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2009, 20 (04) : 790 - 791
  • [7] Erlotinib for relapsed or refractory Non-Small-Cell Lung Cancer after failure of gefitinib
    Nishihira, Ryuichi
    Ogura, Takashi
    Tajiri, Michihiko
    Kato, Terufumi
    Sekine, Akimasa
    Shinohara, Takeshi
    Baba, Tomohisa
    Takahashi, Hiroshi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S703 - S703
  • [8] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Yusuf, Syed W.
    Kim, Peter
    Durand, Jean-Bernard
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [9] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [10] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
12345